MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Quanterix Corp

Закрыт

СекторЗдравоохранение

5.84 -1.68

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

5.84

Макс.

5.91

Ключевые показатели

By Trading Economics

Доход

-9.5M

-30M

Продажи

-5.9M

24M

Рентабельность продаж

-122.622

Сотрудники

471

EBITDA

-11M

-37M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+0.34% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

11 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

60M

273M

Предыдущая цена открытия

7.52

Предыдущая цена закрытия

5.84

Новостные настроения

By Acuity

58%

42%

298 / 371 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Neutral Evidence

Quanterix Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

19 окт. 2025 г., 20:00 UTC

Приобретения, слияния, поглощения

Infratil Agrees to NZ$437.7 Million Deal to Raise Contact Energy Stake

19 окт. 2025 г., 23:44 UTC

Обсуждения рынка

Gold Edges Lower Amid Signs of U.S.-China Trade Tensions Easing -- Market Talk

19 окт. 2025 г., 23:37 UTC

Обсуждения рынка

New Zealand's Core CPI Keeps Rate Cut Hopes Alive -- Market Talk

19 окт. 2025 г., 23:36 UTC

Обсуждения рынка

Nikkei May Rise, Tracking Wall Street Gains -- Market Talk

19 окт. 2025 г., 23:36 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

19 окт. 2025 г., 23:09 UTC

Обсуждения рынка

Could Rio Tinto, BHP Ally to Defend Iron-Ore Pricing Power? -- Market Talk

19 окт. 2025 г., 22:41 UTC

Приобретения, слияния, поглощения

Luxury Fashion House Kering Confirms Beauty Deal With L'Oréal -- Barrons.com

19 окт. 2025 г., 22:30 UTC

Отчет

Stock Futures Rise Ahead of Major Week of Earnings -- Barrons.com

19 окт. 2025 г., 22:18 UTC

Обсуждения рынка

Gold at $5,000 on Cards as Investors Get Comfortable -- Market Talk

19 окт. 2025 г., 21:50 UTC

Обсуждения рынка

Infratil's Contact Stake Buy May Require Bigger Asset Sales -- Market Talk

19 окт. 2025 г., 21:15 UTC

Обсуждения рынка

Investors Need to Change Narrative Toward Scales -- Market Talk

19 окт. 2025 г., 19:34 UTC

Приобретения, слияния, поглощения

Infratil's Contact Shareholding to Rise to 14.3% When Deal Completes

19 окт. 2025 г., 19:34 UTC

Приобретения, слияния, поглощения

Infratil to Issue New Shares Worth NZ$218.8 Million to TECT at NZ$12.43 Each

19 окт. 2025 г., 19:33 UTC

Приобретения, слияния, поглощения

Infratil Part-Funding Purchase of Contact Energy Stake With NZ$218.8 Million of Existing Debt

19 окт. 2025 г., 19:32 UTC

Приобретения, слияния, поглощения

Infratil Acquiring Additional Contact Energy Stake for NZ$8.95/Share

19 окт. 2025 г., 19:32 UTC

Приобретения, слияния, поглощения

Infratil Acquiring Contact Energy Stake for NZ$437.7 Million

19 окт. 2025 г., 19:31 UTC

Приобретения, слияния, поглощения

Infratil Acquiring TECT Holdings's Shareholding in Contact Energy

19 окт. 2025 г., 19:31 UTC

Приобретения, слияния, поглощения

Infratil to Acquire Additional 4.92% Stake in Contact Energy

19 окт. 2025 г., 16:29 UTC

Отчет

Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings -- Barrons.com

19 окт. 2025 г., 11:14 UTC

Отчет

Zijin Mining 3Q Oper Income CNY86.49B; up 8.1% on Year>2899.HK

19 окт. 2025 г., 11:14 UTC

Отчет

Zijin Mining: Higher Sales of Gold, Copper Supported Results >2899.HK

19 окт. 2025 г., 11:14 UTC

Отчет

Zijin Mining 3Q Net CNY14.57B; up 57.1% on Year>2899.HK

18 окт. 2025 г., 13:30 UTC

Приобретения, слияния, поглощения

Deal Expected to Value Unit at Roughly $4B, Sources Say -- WSJ

18 окт. 2025 г., 13:30 UTC

Приобретения, слияния, поглощения

Deal Could Be Announced as Soon as Next Week, Sources Say -- WSJ

18 окт. 2025 г., 13:30 UTC

Приобретения, слияния, поглощения

Gucci Owner Kering Nears $4 Billion Sale of Beauty Unit to L'Oréal -- WSJ

18 окт. 2025 г., 13:30 UTC

Приобретения, слияния, поглощения

Gucci Parent Kering in Talks to Sell Beauty Business to L'Oréal, Sources Say -- WSJ

18 окт. 2025 г., 08:20 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

17 окт. 2025 г., 23:25 UTC

Приобретения, слияния, поглощения

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17 окт. 2025 г., 22:15 UTC

Обсуждения рынка

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17 окт. 2025 г., 21:15 UTC

Обсуждения рынка

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

Сравнение c конкурентами

Изменение цены

Quanterix Corp Прогноз

Целевая цена

By TipRanks

0.34% рост

Прогноз на 12 месяцев

Средняя 5.88 USD  0.34%

Максимум 7 USD

Минимум 5 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Quanterix Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

4 ratings

0

Покупка

4

Удержание

0

Продажа

Техническая оценка

By Trading Central

5.34 / 6.015Поддержка и Сопротивление

Краткосрочная

Neutral Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Настроения

By Acuity

298 / 371Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat